What is Charles River Laboratories International Market Cap?
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Charles River Laboratories International's share price for the quarter that ended in Dec. 2023 was $236.4. Charles River Laboratories International's Shares Outstanding (EOP) for the quarter that ended in Dec. 2023 was 51 Mil. Therefore, Charles River Laboratories International's market cap for the quarter that ended in Dec. 2023 was $12,136 Mil.
Charles River Laboratories International's quarterly market cap
declined
from Jun. 2023 ($10,779 Mil) to Sep. 2023 ($10,053 Mil) but then
increased
from Sep. 2023 ($10,053 Mil) to Dec. 2023 ($12,136 Mil).
Charles River Laboratories International's annual market cap
declined
from Dec. 2021 ($19,020 Mil) to Dec. 2022 ($11,101 Mil) but then
increased
from Dec. 2022 ($11,101 Mil) to Dec. 2023 ($12,136 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Charles River Laboratories International's Enterprise Value for Today is $15,123 Mil.
Charles River Laboratories International Market Cap Historical Data
The historical data trend for Charles River Laboratories International's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Charles River Laboratories International Market Cap Chart
Charles River Laboratories International Annual Data
Competitive Comparison of Charles River Laboratories International's Market Cap
For the Diagnostics & Research subindustry, Charles River Laboratories International's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Charles River Laboratories International's Market Cap Distribution in the Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Charles River Laboratories International's Market Cap distribution charts can be found below:
* The bar in red indicates where Charles River Laboratories International's Market Cap falls into.
Charles River Laboratories International Market Cap Calculation
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Charles River Laboratories International's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Charles River Laboratories International (NYSE:CRL) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Charles River Laboratories International Market Cap Related Terms
Thank you for viewing the detailed overview of Charles River Laboratories International's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.
Charles River Laboratories International (Charles River Laboratories International) Business Description
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
CRL has been successfully added to your 